Linda Raschke sees potential in pharmaceutical stocks amid database adjustments

Linda Raschke sees potential in pharmaceutical stocks amid database adjustments
Raschke shifts portfolio focus

Linda Raschke has decided to remove Workday Inc. (WDAY) from her data set, indicating a shift in focus. In contrast, Raschke highlights a growing need for pharmaceutical companies, mentioning Johnson & Johnson (JNJ) and Eli Lilly and Co. (LLY) as examples. This suggests a potential interest in the pharmaceutical sector amidst market changes.

Raschke's recent repositioning aligns with her broader approach to adapting in dynamic markets, drawing on foundational principles she outlined when addressing trading strategies around daily swing levels. Her renewed interest in pharmaceuticals further builds on the emphasis she has placed on trade execution in breakout markets, highlighting the critical role of sector rotation and timely decision-making amid shifting market landscapes.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.